Table 4.

Brain activity pertaining to fear renewal in combat control subjects

AreaSideCoordinates (mm)K (voxels)Z-scorep-FWE
Fear renewal: CS+E vs CS− in combat control participants
    Amygdala*L0
    Amygdala*R0
    Hippocampus*L0
    Hippocampus*R0
    Insula*L39, 12, −32294.090.003
    Insula*R39, 3, −32203.950.003
    vmPFC*R0
    Parietal lobeL63, −54, 271834.170.033
    Parietal lobeR63, −51, 271973.670.023
Fear renewal: response to renewed CS+ in combat controls relative to PTSD patients
    Amygdala*L21, −6, −25293.560.038
    Amygdala*R24, 0, −27153.250.057
    Hippocampus*L21, 3, −27103.090.166
    Hippocampus*R18, 6, −27303.190.098
    Insula*L30, 12, −18143.220.153
    Insula*R0
    vmPFC*R9, 51, −15263.480.017
    Parietal lobe/precuneus0, −60, 453943.710.022
    Occipital lobe/cuneusR6, −84, 333.63
Fear renewal: response to CS− in combat controls relative to PTSD patients
    Amygdala*L0
    Amygdala*0
    Hippocampus*L24, −24, −9573.600.013
    Hippocampus*R24, −18, −27242.870.170
    Insula*L0
    Insula*R0
    vmPFC*0
    CerebellumL27, −54, −273073.500.022
    Occipital lobe/fusiform gyrus−27, −63, −153.30
  • No effects of renewal (CS+ vs CS−) were found in PTSD patients, or when analyzing across all participants. Combat controls displayed enhanced activity in the vmPFC and amygdala to the CS+ and hippocampal activation to the CS−, relative to PTSD patients. In contrast, PTSD patients did not display any significant activation to CS+ or CS− relative to Combat Controls, signaling a reduced capacity for context to induce a renewal response. All activation FWE p < 0.05, bold denotes peak global maxima within a cluster.

  • *Indicates SVC.